Hortifrut (HF-B) Q3 2025 earnings summary

Executive summary

• Revenue for the nine months ended September 30, 2025, was $842.1M, up from $759.5M year-over-year, but net loss reached $56.1M compared to a profit of $12.6M in the prior year.

• Gross margin for the period was $107.2M, down from $114.9M year-over-year, reflecting higher costs and significant asset impairments.

• The company reported a basic loss per share of $(0.00000103) for the period, compared to earnings of $0.00000015 per share in the previous year.

Financial highlights

• Operating income for the nine months was $53.3M, down from $67.5M year-over-year.

• Asset impairments totaled $80.6M, a significant increase from $14.0M in the prior year, mainly due to the write-off of unproductive biological assets in Mexico, China, and Peru.

• Net financial costs were $34.1M, up slightly from $33.7M year-over-year.

• Cash and equivalents at period end were $51.7M, down from $67.9M at year-end 2024.

• Total assets decreased to $1.77B from $1.86B at year-end 2024.

Outlook and guidance

• Management expects sufficient liquidity and cash flow to meet obligations for the next 12 months, supported by available credit lines of $528.9M and EUR17.5M.

• The company continues to focus on operational efficiency, cost control, and market expansion, especially in North America, Europe, and Asia.